Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Multiple drug intolerance syndrome (MDIS) describes patients with multiple nonimmunologically mediated adverse reactions to medications. Patients with more than 10 medication intolerance labels are considered to have severe MDIS. There is overlap in the characteristics of patients with MDIS and fibromyalgia and irritable bowel syndrome (IBS). Severe MDIS can limit treatment options in this already complex patient group.
Objective: This study assessed the prevalence of severe MDIS in patients with fibromyalgia and IBS and its associated risk factors.
Methods: A retrospective chart review identified patients diagnosed with fibromyalgia or IBS who had been seen at a large academic center from August 2019 to July 2020. Exact birthdate- and sex-matched controls who had been seen within the same time frame were selected at random. Listed drug intolerance data and patient characteristics were then analyzed with logistic regression and χ testing.
Results: Patients with fibromyalgia and IBS were 12 and 3 times more likely to have severe MDIS compared with controls, respectively. Severe MDIS was associated with polypharmacy in both groups. Opiates were the most frequently reported drug intolerance across all participants. Although patients with IBS more often reported gastrointestinal symptoms as adverse reactions, individuals with fibromyalgia did not more frequently report pain or behavioral changes as adverse reactions.
Conclusions: There was an increased rate of severe MDIS in patients diagnosed with fibromyalgia and IBS. Additional studies are needed to better understand the morbidity of MDIS and how it can best be managed in patients with fibromyalgia and IBS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaip.2024.01.021 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Predictive value of Periotest® assessment for failure of Mini Dental Implants supporting maxillary overdentures: a pilot study.
J Stomatol Oral Maxillofac Surg
July 2025
Department of Plastic, Oral and Maxillo-Facial Surgery, Ghent University Hospital, Ghent, Belgium; Het Tandplein, Private Clinic for Dentistry and Oral and Maxillo-Facial Surgery, Brugge, Belgium. Electronic address:
Objective: This prospective cohort study assesses the long-term (5 years) clinical outcome of mini dental implants (MDIs) supporting maxillary overdentures with Periotest® and explores the applicability of Periotest® values (PTV) to predict implant failure.
Materials And Methods: Included patients were edentulous in the maxilla, dissatisfied with their conventional dentures, and reluctant to undergo augmentation procedures. Per patient, 5 to 8 MDIs (ILZ, Southern Implants Inc.
Registration and Real-Life Studies on Automated Insulin Delivery Systems.
J Diabetes Sci Technol
July 2025
Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Introduction: The Diabetes Control and Complications Trial (DCCT) clearly documented long-term beneficial effects on both micro- and macro-vascular complications associated with type 1 diabetes (T1D) by using intensive insulin therapy (IIT) via multiple daily injections (MDIs) or insulin pumps more than 30 year ago. IIT, both during the DCCT and with translation into clinical practice, has been demonstrated to increase the risk of severe hypoglycemia and weight gain. Automated insulin delivery (AID) systems have become the standard of care in T1D management in the developed countries.
View Article and Find Full Text PDF[Multiple hypersensitivity versus multiple intolerance to drugs].
Rev Med Suisse
April 2025
Service d'immunologie et allergologie, Hôpitaux universitaires de Genève, 1211 Genève 14.
In everyday practice, many patients experience reactions to substances from different drug families. Multiple Drug Hypersensitivity Syndrome (MDHS) and Multiple Drug Intolerance Syndrome (MDIS) both involve reactions to several unrelated drugs but differ in pathophysiology and clinical presentation. Rare and immune-mediated, MDHS involves T lymphocytes and presents with severe delayed exanthems, eosinophilia, and moderate hepatic cytolysis triggered by at least two chemically distinct drugs.
View Article and Find Full Text PDFThe Relationship Between the Percent Coefficient of Variation of Sensor Glucose Levels and the Risk of Severe Hypoglycemia or Non-Severe Hypoglycemia in Patients With Type 1 Diabetes: Post Hoc Analysis of the ISCHIA Study.
J Diabetes Sci Technol
February 2025
Division of Preventive Medicine, Clinical Research Institute, NHO Kyoto Medical Center, Kyoto, Japan.
Background: The relationship between the percent coefficient of variation (%CV) and the risk of severe hypoglycemia (SH) or non-severe hypoglycemia (NSH) in patients with type 1 diabetes (T1D) remains to be elucidated.
Materials And Methods: The Effect of Intermittent-Scanning Continuous Glucose Monitoring to Glycemic Control Including Hypoglycemia and Quality of Life of Patients with Type 1 Diabetes Mellitus (ISCHIA) study was a crossover, randomized, controlled trial for hypoglycemia prevention in patients with T1D using multiple daily injections (MDIs). Blinded continuous glucose monitoring (CGM) data of 93 patients obtained during the Control period (84 days) were used for the post hoc analysis.
Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma.
Biomedicines
January 2025
Department of Pulmonary Medicine, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
: Metered-dose inhalers (MDIs) and dry powder inhalers (DPIs) are common inhaled corticosteroid (ICS) inhaler devices. The difference in formulation and administration technique of these devices may influence oral cavity microbiota composition. We aimed to compare the saliva microbiome in children with moderate-to-severe asthma using ICS via MDIs versus DPIs.
View Article and Find Full Text PDF